Ubiquitin-like Molecule ISG15 Acts as an Immune Adjuvant to Enhance Antigen-specific CD8 T-cell Tumor Immunity.
about
Combination GITR targeting/PD-1 blockade with vaccination drives robust antigen-specific antitumor immunity.ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinomaCurrent state in the development of candidate therapeutic HPV vaccinesISGylation - a key to lock the cell gates for preventing the spread of threats.
P2860
Ubiquitin-like Molecule ISG15 Acts as an Immune Adjuvant to Enhance Antigen-specific CD8 T-cell Tumor Immunity.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Ubiquitin-like Molecule ISG15 ...... fic CD8 T-cell Tumor Immunity.
@ast
Ubiquitin-like Molecule ISG15 ...... fic CD8 T-cell Tumor Immunity.
@en
type
label
Ubiquitin-like Molecule ISG15 ...... fic CD8 T-cell Tumor Immunity.
@ast
Ubiquitin-like Molecule ISG15 ...... fic CD8 T-cell Tumor Immunity.
@en
prefLabel
Ubiquitin-like Molecule ISG15 ...... fic CD8 T-cell Tumor Immunity.
@ast
Ubiquitin-like Molecule ISG15 ...... fic CD8 T-cell Tumor Immunity.
@en
P2093
P2860
P356
P1433
P1476
Ubiquitin-like Molecule ISG15 ...... fic CD8 T-cell Tumor Immunity.
@en
P2093
Daniel O Villarreal
David B Weiner
Laurence M Wood
Megan C Wise
Rebekah J Siefert
P2860
P304
P356
10.1038/MT.2015.120
P577
2015-06-30T00:00:00Z